nimotuzumab
biocon,daiichi sankyo,oncoscience
['nimotuzumab', 'pancsm', 'pancreatic']
last but not least nimotuzumab in kras wild type #pancreaticcancer presented at #asco2022 nimotuzumab is an anti-egfr monoclonal antibody. #pancsm #precisionmedicine 
Physician-scientist passionate about #PrecisionOncology ?? & #PancreaticCancer ?? •@myesmo faculty •Rolling with @OncoAlert?? •Views are my own•